TABLE 2.
Two‐year clinical outcome of acute MI versus non‐MI patients
| Acute MI n = 1,275 | Non‐MI n = 1,213 | HR (95%‐CI) | Plog‐rank | Adjusted HRa (95%‐CI) | p value | |
|---|---|---|---|---|---|---|
| Target vessel failure | 77 (6.1) | 103 (8.6) | 0.70 (0.52–0.94) | .017 | 0.81 (0.60–1.10) | .17 |
| Cardiac death | 17 (1.3) | 15 (1.3) | 1.08 (0.54–2.16) | .83 | 1.37 (0.68–2.77) | .38 |
| Target vessel MI | 28 (2.2) | 34 (2.9) | 0.78 (0.47–1.28) | .33 | 0.94 (0.57–1.57) | .82 |
| Clinically indicated TVR | 51 (4.1) | 72 (6.1) | 0.67 (0.47–0.96) | .026 | 0.76 (0.52–1.09) | .13 |
| Target lesion failure | 63 (5.0) | 84 (7.0) | 0.70 (0.51–0.98) | .034 | 0.82 (0.59–1.14) | .23 |
| Clinically indicated TLR | 37 (3.0) | 52 (4.4) | 0.67 (0.44–1.03) | .06 | 0.76 (0.49–1.16) | .20 |
| Definite‐or‐probable stent thrombosis | 9 (0.7) | 9 (0.8) | 0.95 (0.38–2.39) | .91 | 1.20 (0.47–3.07) | .71 |
| Definite stent thrombosis | 7 (0.6) | 9 (0.8) | 0.74 (0.28–1.98) | .54 | 0.90 (0.33‐2.45) | .83 |
Note: Values are n(%).
Abbreviations: CI, confidence interval; HR, hazard ratio; MI, myocardial infarction; TLR, target lesion revascularization; TVR, target vessel revascularization.
a
Adjusted for sex, diabetes, previous MI, and previous coronary artery bypass grafting.